Related Experiment Video
Updated: Jul 18, 2025

04:59
Author Spotlight: Developing a Disposable Dosator for Preclinical Testing of Dry Powder Inhalers in Small Animal Models
Published on: August 18, 2023
908
Disposable Dosators Intended for Dry Powder Delivery to Mice
Sara E Maloney1, Ian E Stewart2, Jeffrey B Mecham2
1Technology Advancement and Commercialization, RTI International; smaloney@rti.org.
Journal of Visualized Experiments : Jove
|August 22, 2023
Summary
Disposable syringe dosators enable accurate dry powder pulmonary drug delivery in mice. This innovation overcomes limitations in small animal models, facilitating reproducible proof-of-concept studies for inhaled pharmaceuticals.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Inhalation Technology
Background:
- Dry powder inhalers (DPIs) offer advantages like stable formulations and propellant-free delivery for lung drug administration.
- In vivo testing in murine models is crucial for pharmaceutical aerosol product development, but lacks suitable delivery devices for small animals.
Purpose of the Study:
- To develop and evaluate disposable syringe dosators for accurate and reproducible intrapulmonary dry powder delivery in mice.
- To address the limitations of existing technology in murine models for pulmonary drug delivery research.
Main Methods:
- Development of disposable syringe dosators for loading and delivering precise dry powder doses.
- Utilizing a tamping mechanism with a blunt needle to control powder quantity.
- Testing with four model spray-dried powders to assess dose reproducibility and influencing factors.
Main Results:
- The developed dosators successfully delivered doses ranging from 30 to 1100 µg.
- Achieved dose was influenced by tamping frequency, needle size, and powder formulation.
- Dosators demonstrated ease of manufacturing, cost-effectiveness, and suitability for animal procedure rooms.
Conclusions:
- Disposable syringe dosators effectively overcome a significant hurdle in murine dry powder delivery.
- This technology enables more accurate and reproducible preliminary studies in small animal models for pulmonary drug delivery.
- Facilitates cost-effective proof-of-concept studies for inhaled pharmaceutical products.

